Tawada Healthcare Secures Tens of Millions in Series A+ Funding to Expand Distribution Network and Manufacturing Capabilities

Recently, Tawada Healthcare (THC) announced the completion of its Series A+ financing, raising tens of millions of U.S. dollars through an exclusive investment from the HLC USD Fund. This marks another significant funding milestone for THC, following its earlier investment from the International Finance Corporation (IFC), a member of the World Bank Group. The proceeds from this round will be used to further expand its sales network, gradually build manufacturing capabilities, and actively participate in the “Health System Strengthening” (HSS) project promoted by the Indonesian Ministry of Health and funded by multilateral development banks.

HLC has fully leveraged its ecosystem empowerment capabilities to help THC connect with leading medical device companies in its investment portfolio, assist THC in optimizing its brand portfolio, facilitate the transfer of production technologies, and achieve high-quality collaboration.

THC, established in 1999, is a leading integrated medical device service provider in Indonesia. It has forged strategic partnerships with 55 top-tier global medical brands and serves over 3,000 healthcare institutions across Southeast Asia, including hospitals, clinics, medical centers, and laboratories. With branches in 28 regions and more than 700 professional staff members, THC has built a comprehensive distribution and service network.

Indonesia, the most populous country in Southeast Asia with 281 million people, has recently seen its Ministry of Health launch a $4 billion "Health System Strengthening Project" in collaboration with multiple multilateral development banks, aiming to comprehensively upgrade medical facilities and testing capabilities. This investment marks HLC’s second major project in Southeast Asia following its investment in Etana Biologics, designed to promote local healthcare development while assisting Chinese medical device companies in achieving high-quality global expansion.